Stem Cells in the Treatment of Cardiovascular Disease-An Overview

Stem Cell Reviews and Reports

Volumn 8, Issue 2, 2012, Pages 494-502

  Hotkar, Amita J ^a   Balinsky, Warren ^a  

^a NEW SCHOOL FOR SOCIAL RESEARCH   (United States)

Author keywords

Adult stem cells; Cardiac regeneration; Cardiovascular disease; Cell therapy; Embryonic stem cells; Neovascularization

Indexed keywords

ANIMAL; ARTICLE; CARDIOVASCULAR DISEASE; CYTOLOGY; HUMAN; STATISTICS; STEM CELL; STEM CELL TRANSPLANTATION; UNITED STATES;

ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; STEM CELL TRANSPLANTATION; STEM CELLS; UNITED STATES;

EID: 84861660994     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-011-9302-2     Document Type: Article

References (64)

1. Strelchenko, N., Verlinsky, O., Kukharenko, V., & Verlinsky, Y. (2004). Morula-derived human embryonic stem cells. Reproductive Biomedicine Online, 9(6), 623-629.
2. WHO, 2004 data. http://www.who.int/cardiovascular_diseases/en/cvd_atlas_01_types.pdf. Accessed April 6, 2010.
3. WHO. (2002). In C. Murray & A. Lopez (Eds.), World health report: Reducing risks, promoting healthy life. France: World Health Organization.
4. Chockalingam, A., & Balaguer-Vintro. (2003). Impending global pandemic of cardiovascular diseases: challenges and opportunities for the prevention and control of cardiovascular diseases in developing countries and economies in transition. World Heart Federation. Barcelona: Prous Science.
5. American Heart Association (2010). Cardiovascular Disease Cost, 2009. http://www.americanheart.org/presenter.jhtml?identifier=4475. Accessed May 5, 2010.
6. Wert, G., & Mummery, C. (2003). Human embryonic stem cells: Research, ethics and policy. Human Reproduction, 18(4), 672-682.
7. Juengst, E., & Fossel, M. (2000). The ethics of embryonic stem cells- now and forever, cells without end. JAMA, 284(24), 3180-3184.
8. Muller-Ehmsen, J., Whittaker, P., Kloner, R., Dow, J., et al. (2002). Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. Journal of Molecular and Cellular Cardiology, 34, 107.
9. Chester, R., & Sackstein, R. (2010). Embryonic stem cell-based therapeutics: Balancing scientific progress and bioethics. Health Matrix: Journal of Law-Medicine, 20(1-15), 91.
10. Mummery, C., Oostwaard, D., Doevendans, P., et al. (2003). Differentiation of human embryonic stem cells to cardiomyocytes. Circulation. doi: 10. 1161/01.
11. Kehat, I., Dorit, K., Mirit, S., et al. (2001). Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. The Journal of Clinical Investigation, 108(3), 407-414.
12. Mummery, C., & Robert, P. (2003). Origin and use of embryonic and adult stem cells in differentiation and tissue repair. Oxford Journal, Medicine cardiovascular research, 58(2), 324-335.
13. Hochedlinger, K., & Jaenisch, R. (2003). Nuclear transplantation, embryonic stem cells, and the potential for cell therapy. The New England Journal of Medicine, 349(3), 275-286.
14. Kawase, E. (2000). Mouse embryonic stem cell lines established from neuronal cell derived cloned blastocysts. Genesis, 28(3), 156.
15. Katja, S., & MacLellan, R. (2009). Induced pluripotent stem cells: It's like déjà vu all over again. Circulation, 120(1), 1462-1464.
16. Tong, Ng Y., & Ng, S. (2002). Somatic cell nuclear transfer (Cloning): Implications for the medical practitioner. Singapore Medical Journal, 43(7), 369-376.
17. Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663-676.
18. Hochedlinger, K., & Plath, K. (2009). Epigenetic reprogramming and induced pluripotency. Development, 136, 509-523.
19. Shin-ichi, N., et al. (2008). The promise of human induced pluripotent stem cells for research and therapy. Nature Reviews. Molecular Cell Biology, 9(9), 725-729.
20. Yu, J., Hu, K., Smuga-Otto, K., et al. (2009). Human induced pluripotent stem cells free of vector and transgene sequences. Science, 324, 797-801.
21. Schenke-Layland, K., Rhodes, K., & Angelis, E. (2008). Reprogrammed mouse fibroblasts differentiate into cells of the cardiovascular and hematopoietic lineages. Stem Cells, 26, 1537-1546.
22. Mauritz, C., Schwanke, K., Reppel, M., et al. (2008). Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation, 118, 507-517.
23. Narazaki, G., Uosaki, H., Teranishi, M., et al. (2008). Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation, 118, 498-506.
24. Zwi, L., Caspi, O., Arbel, G., et al. (2009). Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation, 120, 1513-1523.
25. Freund, C., Davis, R. P., Gkatzis, K., et al. (2010). The first reported generation of human induced pluripotent stem cells (iPS cells) and iPS cell-derived cardiomyocytes in the Netherlands. Netherlands Heart Journal, 18(1), 51-54.
26. Zhao, T., Zhang, Z. N., Rong, Z., et al. (2011). Immunogenicity of induced pluripotent stem cells. Nature. doi: 10. 1038/nature10135.
27. Chun, Y. S., Chaudhari, P., & Jang, Y. Y. (2010). Applications of patient-specific induced pluripotent stem cells; focused on disease modeling, drug screening and therapeutic potentials for liver disease. International Journal of Biological Sciences, 6, 796-805.
28. Laflamme, et al. (2007). Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nature Biotechnology, 9, 1015-1024.
29. Orlic, D., Kajstura, J., Chimenti, S., et al. (2001). Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proceedings of the National Academy of Sciences of the United States of America, 98, 10344.
30. Seiler, C., Pohl, T., Wustmann, K., et al. (2001). Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study. Circulation, 104, 2012.
31. Vasa, M., Fichtlscherer, S., Adler, K., et al. (2001). Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. American Heart Association, 103, 2885-2890.
32. Asahara, T., Murohara, T., Sullivan, A., et al. (1997). Isolation of putative endothelial progenitor cells for angiogenesis. Science, 275, 964-967.
33. Lin, Y., Weisdorf, D., & Solovey, A. (2000). Origins of circulating endothelial cells and endothelial outgrowth from blood. The Journal of Clinical Investigation, 105, 71-77.
34. Kocher, A., Schuster, M., et al. (2001). Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nature Medicine, 7, 430-436.
35. Huang Ngan, F., & Song, L. (2008). Mesenchymal stem cells for vascular regeneration. Regenerative Medicine, 3(6), 877-892.
36. Pittenger, M. F., & Martin, B. J. (2004). Mesenchymal stem cells and their potential as cardiac therapeutics. Circulation Research, 95, 9-20.
37. Pittenger, M. F., & Mosca, J. D. (2000). Human mesenchymal stem cells: progenitor cells for cartilage, bone, fat and stroma. Current Topics in Microbiology and Immunology, 251, 3-11.
38. Toma, C., Pittenger, M. F., Cahill, K., et al. (2002). Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation, 105, 93-98.
39. Devine, S., Bartholomew, A., Mahmud, N., et al. (2001). Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. ExpHematol., 29, 244-255.
40. Ferrari, M., Corradi, A., Lazzaretti, M., et al. (2007). Adult stem cells: Perspectives for therapeutic applications. Veterinary Research Communications, 31(1), 1-8.
41. Min, J. Y., Sullivan, M. F., Yang, Y., Zhang, J. P., Converso, K. L., Morgan, J. P., et al. (2002). Significant improvement of heart function by cotransplantation of human mesenchymal stem cells and fetal cardiomyocytes in postinfarcted pigs. The Annals of Thoracic Surgery, 74, 1568.
42. Shake, J., Gruber, P., & Baumgartner, W. (2003). Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. The Annals of Thoracic Surgery, 73, 1919.
43. Thompson, C., Nasseri, B., Makower, J., et al. (2003). Percutaneous transvenous cellular cardiomyoplasty. A novel nonsurgical approach for myocardial cell transplantation. Journal of the American College of Cardiology, 41, 1964.
44. Ankrum, J., & Karp, J. M. (2010). Mesenchymal stem cell therapy: Two steps forward, one step back. Trends in Molecular Medicine, 16(5), 203-209.
45. Strauer, B., Brehm, M., & Zeus, T. (2001). Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction. Deutsche Medizinische Wochenschrift, 126, 932-938.
46. Therapeutics daily newsletter (2010). http://www.bioheartinc.com. Accessed April 27, 2010.
47. Cedar Sinai Hospital, stem cell therapy (2010). http://www.cedars-sinai.edu/Patients/Programs-and-Services/Heart-Institute/Clinical-Trials/Coronary-Artery-Disease.aspx. Accessed May 2, 2010.
48. Stem Cell Therapeutics Laboratory at Cedars Sinai Hospital (2010). http://www.cedars-sinai.edu/Research-and-Education/Research-Labs/Stem-Cell-Therapeutics-Laboratory.aspx.Accessed January 2, 2011.
49. Laflamme, M., & Murry, C. (2005). Regenerating the heart. Nature Biotechnology, 23, 845-856.
50. Kattman, S. J., Witty, A. D., Gagliardi, M., et al. (2011). Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell, 8(2), 228-240.
51. Fernandes, S., Naumova, A., Zhu, W., et al. (2010). Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats. Journal of Molecular and Cellular Cardiology, 249(6), 941-949.
52. Terrovitis, J., Smith, R., & Marbán, E. (2008). Assessment and optimization of cell engraftment after transplantation into the heart. Circulation Research, 106, 479-494.
53. Chin, M., Mason, M., Xie, W., et al. (2009). Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell, 5, 111-123.
54. Cao, F., Wagner, R., Wilson, K., et al. (2008). Transcriptional and functional profiling of human embryonic stem cell-derived cardiomyocytes. PloS One, 3, e3474.
55. Menasche, P., Alfieri, O., Janssens, S., McKenna, W., Reichenspurner, H., Trinquart, L., et al. (2008). The myoblast autologous grafting in ischemic cardiomyopathy (MAGIC) trial: First randomized placebo-controlled study of myoblast transplantation. Circulation, 117(9), 1189-1200.
56. Burridge, P. W., Thompson, S., Millrod, M. A., et al. (2011). A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. PloS One, 6(4).
57. Hagege, A. A., Marolleau, J. P., Vilquin, J. T., Alheritiere, A., Peyrard, S., Duboc, D., et al. (2006). Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients. Circulation, 114(1), 108-113.
58. Siminiak, T., Kalawski, R., Fiszer, D., Jerzykowska, O., Rzezniczak, J., Rozwadowska, N., et al. (2004). Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: Phase I clinical study with 12 months of follow-up. American Heart Journal, 148(3), 531-537.
59. Amariglio, N., Hirshberg, A., Scheithauer, B., et al. (2009). Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Medicine, 6, 1000029.
60. NIH timeline (2011). http://www.nih.gov/about/director/stemcell/stay_08312010.pdf. Accessed January 21, 2011.
61. National Institute of Health Resources for Stem Cell Research. Stem cell Information. http://stemcells.nih.gov/. Accessed June 2, 2011.
62. Crooks, V. A., & Snyder, J. (2010). Regulating medical tourism. Lancet, 376(9751), 1465-1466.
63. Barclay, E. (2009). Stem-cell experts raise concerns about medical tourism. Lancet, 373(9667), 883-884.
64. Touchette, N. (2003). Stem Cell Transplants for the Heart Face Uncertainties. http://www. genomenewsnetwork. org/articles/11_03/heart_stem_cells. shtml. Accessed May 5, 2010.